# MIMRYLO
> **NDA220605** · New Drug Application · Sponsor: TAKEDA PHARMS AM · Approved 2026-08-28
## Drug
- **FDA Application Number:** NDA220605
- **Application type:** New Drug Application
- **Brand name:** MIMRYLO
- **Generic name:** RUSFERTIDE
- **Active ingredients:** RUSFERTIDE ACETATE
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS AM
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2026-08-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220605)
---
*MORVS · CC0 1.0*